Recap: Agilent Technologies Q2 Earnings

Shares of Agilent Technologies A rose in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share rose 36.62% over the past year to $0.97, which beat the estimate of $0.83.

Revenue of $1,525,000,000 rose by 23.18% from the same period last year, which beat the estimate of $1,400,000,000.

Outlook

Agilent Sees Q3 Adj. EPS $0.97-$0.99 vs $0.91 Estimate, Sales $1.51B-$1.54B vs $1.42B Est.

Agilent Raises FY21 Guidance: Adj. EPS From $3.57-$3.67 To $4.09-$4.14 vs $3.90 Estimate, Sales From $5.6B-$5.7B To $6.15B-$6.21B vs $5.94B Est.

How To Listen To The Conference Call

Date: May 25, 2021

Time: 04:30 PM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fwww.investor.agilent.com%2F&eventid=3082216&sessionid=1&key=2C80AD218F286F621CB9690AD024F55D&regTag=&V2=false&sourcepage=register

Price Action

52-week high: $137.83

52-week low: $83.71

Price action over last quarter: Up 2.56%

Company Overview

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2020 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (33%) and China (20%) representing the largest country concentrations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!